Bibliografía comentada

Rane M, Rohani P, Halloran E. Association of diphtheria-tetanus-acellular pertussis vaccine timelines and number of doses with age specific pertussis risk in infants and young…

Crump J, Thandar Oo W. Salmonella typhiVi polysaccharide conjugate vaccine protects infants and children against typhoid fever. The Lancet Published Online August 9, 2021 Comentario editorial en…

McMillan M, Chandrakumar A, Wang H et al. Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidiscarriage: a systematic review and meta-analysis.…

Rahamimov N, Baturov, V, Shani A et al. Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique…

Mugo N, Eckert L, Odero L et al. Antibody responses to prophylactic quadrivalent human papilomavirus vaccine at 48 months among HIV-infected girls and boys ages 9–14…

World Health Organization. Report of the meeting of the Global Advisory Committee on Vaccine Safety (GACVS). 8-9 June, 2021. Wkly Epidemio Rec 2021;96:321-328 El Global Advisory…

Clarke M, Goodchild L, Evans S et al. Body mass index and vaccine response following influenza vaccination during pregnancy. Vaccine Available online 12 July 2021 Estudio…

World Health Organization. Rotavirus vaccines. WHO Position Paper – July 2021. Wkly Epidemiol Rec 2021;28:301-320 La OMS actualiza su Position Paper acerca de la vacuna frente a…

Ostergaard L, Vesikai T, Senders Sh et al. Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-fHbp for up to 4 years…

Carnalla M, Torres-Ibarra L, Barrientos-Gutiérrez T et al. Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes. Vaccine Available online…

Collins-Fairclough A, Donken R, Nosyk B et al. Non-inferior antibody levels for HPV16/18 after extended two-doses schedules compared with a six-month Interval: findings of a…

Ferdinands J, Gaglani M, Ghamande Sh et al. Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult influenza Vaccine Effectiveness Network. J Infect…

Oakley L, Regan A, Fell D et al. Chidlhood seizures after prenatal exposure to maternal influenza infection: a population-based cohort study from Norway, Australia and…

Martín-Merino E, Castillo-Cano B, Martín-Pérez M et al. Papillomavirus vaccination and Guillain-Barré síndrome among girls: a cohort study. Vaccine 2021;39:4306-4313 Dados los contradictorios resultados relativos a…

McGuinness D, Kaufhold R, McHugh P et al. Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice. Vaccine 2021;39:4231-4237…

Kochhar G, Desai A, Caldera F et al. Effectiveness of recombinant zoster vaccine in patients with inflammatory bowel disease. Vaccine 2021;39:4199-4202 Los pacientes que padecen enfermedad inflamatoria…

Sun Y, Jackson K, Dalmon C et al. Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: a retrospective…

Azziz-Baumgartner E, Grohskopf L, Patel M. Realizing the potential of maternal influenza vaccination. JAMA 2021,325:2257-2259 Al hilo de la publicación de los resultados de un estudio…

Plazza F, Virta M, Paassilta M et al. Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated…

Serra L, Knuf M, Martinon-Torres F et al. Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACYW-TT and monovalent serogroup C…

Bianchi F, Mascipinto S, Stefanizzi P et al. Long-term immunogenicity after measles vaccine vs wild infection: an Italian retrospective cohort study. Hum Vacc Immunother 2021;17:2078-2084…

Kann H, Lehtinen M, Eriksson T et al. Sustained cross-reactive antibody responses after human papilomavirus vaccinations: up to 12 years follow-up in the Finnish Maternity…